Mini Review
Accepted on 26 Jul 2024
Sacituzumab Govitecan in Triple-Negative Breast Cancer: from bench to bedside, and back
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Editorial
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Jul 2024
in Cancer Immunity and Immunotherapy
Opinion
Accepted on 25 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Jul 2024
in Cancer Immunity and Immunotherapy
Review
Published on 25 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Jul 2024
in Cancer Immunity and Immunotherapy
Correction
Accepted on 24 Jul 2024
in Cancer Immunity and Immunotherapy